CollPlant Biotechnologies Ltd SEC filings CLGN

CollPlant Biotechnologies Ltd has 356 filings in SEC EDGAR's recent list, going back to Feb 20, 2015. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

CollPlant Biotechnologies Ltd SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 5, 2026 Nov 5, 2026
6-K Current report (foreign issuer) Nov 4, 2026 Nov 4, 2026
6-K Current report (foreign issuer) Nov 3, 2026 Nov 3, 2026
6-K Current report (foreign issuer) Nov 2, 2026 Nov 2, 2026
6-K Current report (foreign issuer) Oct 29, 2026 Oct 29, 2026
144 Notice of proposed sale Oct 27, 2026 —
D Filing Oct 22, 2026 —
3 Initial insider ownership Oct 19, 2026 Sep 3, 2026
6-K Current report (foreign issuer) Oct 15, 2026 Oct 15, 2026
6-K Current report (foreign issuer) Oct 9, 2026 Oct 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 8, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 8, 2026 —
6-K Current report (foreign issuer) Oct 6, 2026 Oct 6, 2026
6-K Current report (foreign issuer) Sep 30, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 22, 2026 Sep 22, 2026
6-K Current report (foreign issuer) Sep 18, 2026 Sep 18, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
6-K Current report (foreign issuer) Sep 4, 2026 Sep 4, 2026
6-K Current report (foreign issuer) Sep 3, 2026 Sep 3, 2026
6-K Current report (foreign issuer) Sep 1, 2026 Sep 1, 2026
6-K Current report (foreign issuer) Aug 31, 2026 Aug 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 21, 2026 —
6-K Current report (foreign issuer) Aug 18, 2026 Aug 18, 2026
6-K Current report (foreign issuer) Aug 6, 2026 Aug 6, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 31, 2026 —
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
6-K Current report (foreign issuer) Jul 28, 2026 Jul 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 27, 2026 —
D Filing Jul 20, 2026 —
424B3 Prospectus Jul 17, 2026 —
EFFECT Filing Jul 16, 2026 —
F-3 Shelf registration (foreign issuer) Jul 9, 2026 —
6-K Current report (foreign issuer) Jul 7, 2026 Jul 7, 2026
6-K Current report (foreign issuer) Jul 1, 2026 Jul 1, 2026
6-K Current report (foreign issuer) May 29, 2026 May 29, 2026
3 Initial insider ownership Apr 27, 2026 Mar 18, 2026
EFFECT Filing Apr 21, 2026 —
424B3 Prospectus Apr 21, 2026 —
CORRESP Letter to the SEC Apr 17, 2026 —
F-1/A Pre-effective amendment no. 1 to form f-1 Apr 15, 2026 —
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
UPLOAD Letter from the SEC Apr 1, 2026 —
F-1 Registration statement (foreign issuer) Mar 30, 2026 —
6-K Current report (foreign issuer) Mar 26, 2026 Mar 26, 2026
20-F Annual report (foreign issuer) Mar 26, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 24, 2026 Mar 24, 2026
3 Initial insider ownership Mar 19, 2026 Mar 19, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Feb 26, 2026 Feb 26, 2026
6-K Current report (foreign issuer) Feb 23, 2026 Feb 23, 2026
D Filing Feb 17, 2026 —
6-K Current report (foreign issuer) Feb 17, 2026 Feb 17, 2026
6-K Current report (foreign issuer) Feb 6, 2026 Feb 6, 2026
424B5 Prospectus supplement Feb 6, 2026 —
6-K Current report (foreign issuer) Feb 5, 2026 Feb 5, 2026
EFFECT Filing Jan 16, 2026 —
CORRESP Letter to the SEC Jan 15, 2026 —
UPLOAD Letter from the SEC Jan 14, 2026 —
F-3 Shelf registration (foreign issuer) Jan 9, 2026 —
6-K Current report (foreign issuer) Dec 31, 2025 Dec 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 28, 2025 —
6-K Current report (foreign issuer) Nov 26, 2025 Nov 26, 2025
6-K Current report (foreign issuer) Nov 26, 2025 Nov 26, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 7, 2025 —
6-K Current report (foreign issuer) Oct 27, 2025 Oct 27, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 20, 2025 —
6-K Current report (foreign issuer) Oct 20, 2025 Oct 20, 2025
6-K Current report (foreign issuer) Oct 16, 2025 Oct 16, 2025
144 Notice of proposed sale Oct 9, 2025 —
SCHEDULE 13D Ownership over 5% (active) Sep 30, 2025 —
6-K Current report (foreign issuer) Sep 30, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Sep 15, 2025 Sep 15, 2025
6-K Current report (foreign issuer) Sep 12, 2025 Sep 12, 2025
EFFECT Filing Aug 28, 2025 —
POS AM Post-effective amendment no. 1 to form f-1 Aug 20, 2025 —
6-K Current report (foreign issuer) Aug 20, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 14, 2025 Jul 14, 2025
EFFECT Filing Jul 3, 2025 —
424B3 Prospectus Jul 3, 2025 —
CORRESP Letter to the SEC Jul 1, 2025 —
UPLOAD Letter from the SEC Jun 30, 2025 —
F-1 Registration statement (foreign issuer) Jun 17, 2025 —
6-K Current report (foreign issuer) Jun 9, 2025 Jun 9, 2025
6-K Current report (foreign issuer) Jun 4, 2025 Jun 4, 2025
D Filing Jun 4, 2025 —
424B5 Prospectus supplement Jun 2, 2025 —
6-K Current report (foreign issuer) Jun 2, 2025 Jun 2, 2025
6-K Current report (foreign issuer) May 30, 2025 May 30, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) Apr 15, 2025 Apr 15, 2025
20-F Annual report (foreign issuer) Mar 26, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 26, 2025 Mar 26, 2025
6-K Current report (foreign issuer) Feb 24, 2025 Feb 24, 2025
6-K Current report (foreign issuer) Feb 12, 2025 Feb 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 28, 2025 —
6-K Current report (foreign issuer) Nov 27, 2024 Nov 27, 2024
6-K Current report (foreign issuer) Sep 25, 2024 Sep 25, 2024
6-K Current report (foreign issuer) Aug 20, 2024 Aug 20, 2024
6-K Current report (foreign issuer) Aug 20, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 19, 2024 Aug 19, 2024
6-K Current report (foreign issuer) Jul 29, 2024 Jul 29, 2024
6-K Current report (foreign issuer) Jun 6, 2024 Jun 6, 2024
S-8 Employee stock plan registration May 29, 2024 —
6-K Current report (foreign issuer) May 29, 2024 May 29, 2024
6-K Current report (foreign issuer) Apr 4, 2024 Apr 4, 2024
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Feb 15, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
6-K Current report (foreign issuer) Nov 29, 2023 Nov 29, 2023
6-K Current report (foreign issuer) Nov 1, 2023 Nov 1, 2023
6-K Current report (foreign issuer) Oct 10, 2023 Oct 10, 2023
144 Notice of proposed sale Sep 22, 2023 —
6-K Current report (foreign issuer) Sep 21, 2023 Sep 21, 2023
144 Notice of proposed sale Sep 12, 2023 —
6-K Current report (foreign issuer) Sep 1, 2023 Sep 1, 2023
6-K Current report (foreign issuer) Aug 24, 2023 Jun 30, 2023
SC 13G/A Amended ownership over 5% (passive) Jul 24, 2023 —
6-K Current report (foreign issuer) Jul 18, 2023 Jul 18, 2023
6-K Current report (foreign issuer) Jun 26, 2023 Jun 26, 2023
144 Notice of proposed sale Jun 14, 2023 —
6-K Current report (foreign issuer) Jun 8, 2023 Jun 8, 2023
6-K Current report (foreign issuer) May 24, 2023 May 24, 2023
S-8 Employee stock plan registration Apr 18, 2023 —
6-K Current report (foreign issuer) Apr 11, 2023 Apr 11, 2023
6-K Current report (foreign issuer) Apr 4, 2023 Apr 4, 2023
6-K Current report (foreign issuer) Mar 29, 2023 Mar 29, 2023
20-F Annual report (foreign issuer) Mar 29, 2023 Dec 31, 2022
SC 13G Ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2023 —
6-K Current report (foreign issuer) Jan 24, 2023 Jan 24, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 11, 2023 —
EFFECT Filing Jan 10, 2023 —
CORRESP Letter to the SEC Jan 9, 2023 —
UPLOAD Letter from the SEC Jan 6, 2023 —
DEL AM Filing Jan 6, 2023 —
6-K Current report (foreign issuer) Jan 4, 2023 Jan 4, 2023
6-K Current report (foreign issuer) Jan 3, 2023 Jan 3, 2023
F-3 Shelf registration (foreign issuer) Dec 30, 2022 —
6-K Current report (foreign issuer) Dec 1, 2022 Dec 1, 2022
6-K Current report (foreign issuer) Nov 17, 2022 Nov 17, 2022
6-K Current report (foreign issuer) Nov 15, 2022 Nov 15, 2022
6-K Current report (foreign issuer) Nov 7, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Aug 26, 2022 Aug 26, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jun 29, 2022 Jun 29, 2022
6-K Current report (foreign issuer) May 26, 2022 May 26, 2022
6-K Current report (foreign issuer) May 2, 2022 May 2, 2022
6-K Current report (foreign issuer) Apr 14, 2022 Apr 14, 2022
S-8 Employee stock plan registration Mar 25, 2022 —
6-K Current report (foreign issuer) Mar 25, 2022 Mar 25, 2022
20-F Annual report (foreign issuer) Mar 24, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Mar 24, 2022 Mar 24, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 24, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 23, 2022 —
6-K Current report (foreign issuer) Feb 16, 2022 Feb 16, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2022 —
SC 13G Ownership over 5% (passive) Jan 31, 2022 —
6-K Current report (foreign issuer) Jan 5, 2022 Jan 5, 2022
6-K Current report (foreign issuer) Dec 2, 2021 Dec 2, 2021
6-K Current report (foreign issuer) Nov 18, 2021 Nov 18, 2021
6-K Current report (foreign issuer) Nov 15, 2021 Nov 15, 2021
6-K Current report (foreign issuer) Oct 12, 2021 Oct 12, 2021
6-K Current report (foreign issuer) Sep 13, 2021 Sep 13, 2021
6-K Current report (foreign issuer) Sep 9, 2021 Sep 9, 2021
6-K Current report (foreign issuer) Aug 19, 2021 Jun 30, 2021
CT ORDER Filing Aug 18, 2021 —
6-K Current report (foreign issuer) Aug 4, 2021 Aug 4, 2021
6-K Current report (foreign issuer) Jun 25, 2021 Jun 25, 2021
6-K Current report (foreign issuer) Jun 22, 2021 Jun 22, 2021
6-K Current report (foreign issuer) Jun 4, 2021 Jun 4, 2021
6-K Current report (foreign issuer) May 27, 2021 May 27, 2021
6-K Current report (foreign issuer) May 25, 2021 May 25, 2021
6-K Current report (foreign issuer) Mar 26, 2021 Mar 26, 2021
20-F Annual report (foreign issuer) Mar 26, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Mar 1, 2021 Mar 1, 2021
6-K Current report (foreign issuer) Feb 26, 2021 Feb 26, 2021
6-K Current report (foreign issuer) Feb 25, 2021 Feb 25, 2021
6-K Current report (foreign issuer) Feb 18, 2021 Feb 18, 2021
6-K Current report (foreign issuer) Feb 18, 2021 Feb 18, 2021
6-K Current report (foreign issuer) Feb 17, 2021 Feb 17, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 17, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 17, 2021 —
424B5 Prospectus supplement Feb 16, 2021 —
6-K Current report (foreign issuer) Feb 12, 2021 Feb 12, 2021
6-K Current report (foreign issuer) Feb 8, 2021 Feb 8, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2021 —
6-K Current report (foreign issuer) Dec 10, 2020 Dec 10, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CLGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Rehovot, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1631487
Former names
CollPlant Biotechnologies Ltd. (until Jun 20, 2019); CollPlant Holdings Ltd. (until Jun 6, 2019)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.